Biovie Average Equity from 2010 to 2024

BIVI Stock  USD 0.47  0.02  4.08%   
Check Biovie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biovie main balance sheet or income statement drivers, such as Depreciation And Amortization of 189.7 K, Interest Expense of 5.2 M or Selling General Administrative of 13.9 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 8.62. Biovie financial statements analysis is a perfect complement when working with Biovie Valuation or Volatility modules.
  
This module can also supplement various Biovie Technical models . Check out the analysis of Biovie Correlation against competitors.

About Biovie Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Biovie income statement, its balance sheet, and the statement of cash flows. Biovie investors use historical funamental indicators, such as Biovie's Average Equity, to determine how well the company is positioned to perform in the future. Although Biovie investors may use each financial statement separately, they are all related. The changes in Biovie's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biovie's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Biovie Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Biovie. Please read more on our technical analysis and fundamental analysis pages.
BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada. BioVie operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biovie in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biovie's short interest history, or implied volatility extrapolated from Biovie options trading.

Pair Trading with Biovie

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biovie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovie will appreciate offsetting losses from the drop in the long position's value.

Moving together with Biovie Stock

  0.63JNJ Johnson Johnson Financial Report 18th of July 2024 PairCorr

Moving against Biovie Stock

  0.77NUVB Nuvation Bio Financial Report 2nd of May 2024 PairCorr
  0.54IMMP Immutep Ltd ADRPairCorr
  0.51MRKR Marker TherapeuticsPairCorr
The ability to find closely correlated positions to Biovie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biovie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biovie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biovie Inc to buy it.
The correlation of Biovie is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biovie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biovie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biovie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:
Check out the analysis of Biovie Correlation against competitors.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Complementary Tools for Biovie Stock analysis

When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is Biovie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.17)
Return On Assets
(0.81)
Return On Equity
(2.58)
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.